Toggle Main Menu Toggle Search

Open Access padlockePrints

Clinical characterisation of polysulfone LS membrane for renal replacement therapy

Lookup NU author(s): Dr Nicholas Hoenich

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

The solute transport characteristics and biocompatibility of a new polysulfone membrane (Polysulfone LS, Fresenius Medical Care, Bad Homburg, Germany) has been established and compared for two different sizes of dialyser (1.3 and 1.8 m2). The in vivo small molecular clearance of the two sizes of dialyser showed an overlap in performance. Neutropenia was slight and independent of the membrane areas as were changes in C5a(des Arg). The membrane induced neutrophil degranulation characterised by the release of elestase α1 inhibitor complex with time averaged values over 180 minutes related to membrane area (p=0.010). Heparin activity during dialysis with the membrane was within the therapeutic range necessary for anticoagulation (0.3-1.0 IU/ml), but despite this an increase in thrombin antithrombin III levels during treatment was noted. Polysulfone LS extends the range of polysulfone membranes available for clinical use and its performance in such that it may be considered as a membrane for the treatment of patients awaiting a transplant, or in whom use of the high flux therapies may be inappropriate.


Publication metadata

Author(s): Hoenich NA

Publication type: Article

Publication status: Published

Journal: International Journal of Artificial Organs

Year: 2000

Volume: 23

Issue: 6

Pages: 365-370

ISSN (print): 0391-3988

ISSN (electronic): 1724-6040

Publisher: Wichtig Editore Srl

URL: http://www.ncbi.nlm.nih.gov/pubmed/10919753

PubMed id: 10919753


Share